ZBTB7A and breast carcinoma: Additionally, in breast cancer cells, LRF/ZBTB7A has been proposed to participate in transforming growth factor beta (TGF-β) signaling, a critical pathway for tumor progression [76], by binding to specificity protein 1 (SP1) and downregulating Smad4 expression [77].